Sign inJoin waitlistJoin the waitlist

JS

Joy Snider

Professor of Neurology, Aging & Dementia · Washington University/B-JH/SLCH Consortium

Credentials: · · · ·

History

Washington University/B-JH/SLCH Consortium
Present

Dallas County Hospital District-Parkland Memorial Hospital
1989–1993
Univ of Texas Southwestern Med Sch at Dallas
1985–1989

Research

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Nature Medicine · 2021 · 305 citations
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease
Alzheimer s & Dementia · 2012 · 220 citations
Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease
The Journal of Experimental Medicine · 2014 · 194 citations

John Morris
20 papers
Tammie Benzinger
16 papers
Randall Bateman
14 papers
DC
Dennis Choi
12 papers
David Holtzman
9 papers
Suzanne Schindler
9 papers
CD
Christopher van Dyck
8 papers
EM
Eric McDade
8 papers
Lawrence Honig
8 papers · 6 as a resident
Richard Perrin
8 papers
SB
Sarah Berman
8 papers
Clifford Jack
7 papers

Grants

Multidisciplinary Training in Alzheimer and Related Dementias
National Institute on Aging · T32
Contact PI · $2.3M · Washington University
2018–2029
Effect of Suvorexant on Alzheimer's Disease Biomarkers
National Institute on Aging · R01
Contact PI · $1.5M · Washington University
2023–2029
Alzheimer's Disease Research Center
National Institute on Aging · P30
Project lead · $723.8K · Washington University
2020–2025
Regional, Synaptic, Cellular Modulation of Abeta Metabolism
National Institute of Neurological Disorders and Stroke · P01
Project lead · $1.8M · Washington University
2012–2022

Clinical trials

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034